Tune in today at 10:40 a.m. ET to watch our Founder and Chief Executive Officer, Rachel McMinn, participate in a fireside chat at the TD Cowen Genetic Medicines & RNA Summit. A link to the webcast is available here: https://bit.ly/4c8pYKe
Neurogene Inc.’s Post
More Relevant Posts
-
New in this field? Check out this free on-line eLearning course to learn more about the oligonucleotide synthesis workflow - https://lnkd.in/gbzEHtwE
The oligo therapeutics market is growing in promise for treating cancers, genetic diseases, and other conditions. In this video you can watch the oligonucleotide synthesis process as it happens, visualizing the programmed repetitive four-step cycle, a bit like line dancing! Click here to learn more: https://lnkd.in/empg6A5Y #oligonucleotide #oligosynthesis
Oligo synthesis and line dancing
To view or add a comment, sign in
-
Clinical trials for genetic therapies may pose risks and benefits that are different from other CF clinical trials, and asking specific questions can help you understand whether a trial is right for you. Download our guide, “Questions to Ask When Enrolling in a Genetic Therapy Clinical Trial,” to help navigate conversations with your research team. https://lnkd.in/eJZZmQbg
To view or add a comment, sign in
-
Together with the OCRA policy team, our Advocate Leaders are working to advance crucial legislative goals. Learn more about their actions, including efforts to broaden access to biomarker testing and expand genetic testing protections: bit.ly/3wwg6um. #TealAction #OvarianCancer #PatientAdvocacy
To view or add a comment, sign in
-
-
🔬 Discover gene-diseases associations and genetic testing recommendations in vascular anomalies with this week's #researchhighlight! Our vascular anomalies working group's latest study emphasizes the growing importance of genetic testing for somatic variants, offering valuable insights. Collaborating with clinicians and laboratory specialists from 11 European centers, they reviewed genes linked to non-hereditary vascular malformations. The study identified 24 core genes and 45 gene-phenotype associations, providing comprehensive genetic testing recommendations. This pioneering research improves data interpretation, elevates clinical diagnostics, and paves the way for improved patient care and treatment. Find out more about this study: https://lnkd.in/ejz4TJes #vascularanomalies #rarediseases #HealthcareResearch #BetterOutcomes #genetictesting #diagnosticprocess
To view or add a comment, sign in
-
-
Join our webinar at 12:00 PM on May 2nd to how Allysta Pharmaceuticals is developing a completely new treatment for Duchenne Muscular Dystrophy, a genetic disease that affects men starting in childhood. https://hubs.la/Q02tLRDk0
To view or add a comment, sign in
-
-
Join our webinar at 12:00 PM on May 2nd to how Allysta Pharmaceuticals is developing a completely new treatment for Duchenne Muscular Dystrophy, a genetic disease that affects men starting in childhood. https://hubs.la/Q02tLQjX0
To view or add a comment, sign in
-
-
Type 2 Diabetes Development Linked to GWAS-Informed Regulatory Modules. Researchers used transcriptomic and functional analyses to find regulatory modules for early-stage type 2 diabetes, focusing in on a module containing the beta cell-related gene RFX6. http://ow.ly/E17S1054KKj
To view or add a comment, sign in
-
Join our webinar at 12:00 PM on May 2nd to how Allysta Pharmaceuticals is developing a completely new treatment for Duchenne Muscular Dystrophy, a genetic disease that affects men starting in childhood. https://hubs.la/Q02tLKSK0
To view or add a comment, sign in
-
-
CRISPR Technology: Editing Genes to Eradicate Genetic Disorders Discover how CRISPR technology could revolutionize the medical field by editing genes to eliminate genetic disorders like cancer and diabetes. Explore the immense potential of this groundbreaking invention and its impact on improving lives. #CRISPR #GeneticEditing #MedicalBreakthrough #EradicateGeneticDisorders #RevolutionaryInvention #HealthcareAdvancement #GeneTherapy #FutureOfMedicine #EliminateCancer #PreventionAndCure
To view or add a comment, sign in
-
【Sysmex and Hitachi High-Tech Agree to Collaborate on Development of New Genetic Testing Systems】 Sysmex Corporation and Hitachi High-Tech Corporation announce that both companies have agreed to collaborate in the development of genetic testing systems based on capillary electrophoresis sequencers . This decision comes from discussions based on the findings of joint research carried out since the conclusion of a feasibility study (FS) agreement in August 2023 aimed at developing new genetic testing systems. To achieve widespread clinical realization, Sysmex and Hitachi High-Tech will develop more efficient genetic testing systems at a lower cost, aiming at expanding optimal genetic testing for individual diseases. https://lnkd.in/gqZD6TRV
To view or add a comment, sign in
-